RMDA: Healthy Pullback After Triangle Target, Long-Term Bullish
📊 RMDA: Healthy Pullback After Triangle Target, Long-Term Bullish 📈
🏛️ The Fundamentals:
RMDA remains a solid pharmaceutical growth story with strong export potential, defensive healthcare demand and a diversified product portfolio. 💊
However, pharmaceutical sector valuations have become relatively expensive, so I would not consider RMDA a cheap stock at current multiples. 💰
Its current valuation is still broadly within the sector range, but the sector itself is trading at elevated levels. 📊
📈 The Pulse:
RMDA reached the extension target of its previous triangle pattern and has now started a pullback. 📐
There is no reason to panic at this stage because the pullback is happening with relatively low liquidity, suggesting limited selling pressure. 📉
The broader bullish structure remains intact as long as price holds above the 5.75 EGP support level. 🛡️
For me, RMDA is better treated as a long-term investment position rather than a short-term trade. 📈
A renewed bullish wave above the recent high around 7.40 EGP would confirm the continuation of the long-term uptrend. 🚀
🧱 The Key Structural Boundaries:
Breakout Trigger: Reclaiming and breaking the ATH around 7.40 EGP with renewed momentum 🚀
First Target: 7.40 EGP, the previous ATH 🎯
Second Target: 7.80 EGP, my calculated fair value 💰
Final Target: 9.80 EGP, the long-term Fibonacci extension target 🚀
🛡️ Risk Management:
As long as RMDA remains above 5.75 EGP, I would not exit the position. 🛡️
A confirmed break below 5.75 EGP would weaken the current bullish structure and invalidate my long-term setup. ⚠️
🎯 Verdict:
RMDA is going through a normal cooling phase after reaching the triangle extension target. 📊
The low liquidity during the pullback is a positive sign and does not currently indicate aggressive distribution. 📉
The key level remains 5.75 EGP, and holding above it keeps the long-term bullish thesis alive. 📈
I would treat RMDA as a long-term investment and look for another bullish wave toward 7.40 EGP, 7.80 EGP and eventually 9.80 EGP. 🎯
🕌 Sharia Compliance:
Status: Compliant, subject to the latest EGX 33 Shariah Index screening. ☪️
RMDA is included in the EGX 33 Shariah Index, but investors should verify the latest screening before making a Sharia-based investment decision. 📋
If you like my insights, follow and boost! 🙌💙🚀 🎁 $15 TradingView Discount: tradingview.com/pricing/?share_your_love=mnmabroukw36ix ✨💸🤑
🏛️ The Fundamentals:
RMDA remains a solid pharmaceutical growth story with strong export potential, defensive healthcare demand and a diversified product portfolio. 💊
However, pharmaceutical sector valuations have become relatively expensive, so I would not consider RMDA a cheap stock at current multiples. 💰
Its current valuation is still broadly within the sector range, but the sector itself is trading at elevated levels. 📊
📈 The Pulse:
RMDA reached the extension target of its previous triangle pattern and has now started a pullback. 📐
There is no reason to panic at this stage because the pullback is happening with relatively low liquidity, suggesting limited selling pressure. 📉
The broader bullish structure remains intact as long as price holds above the 5.75 EGP support level. 🛡️
For me, RMDA is better treated as a long-term investment position rather than a short-term trade. 📈
A renewed bullish wave above the recent high around 7.40 EGP would confirm the continuation of the long-term uptrend. 🚀
🧱 The Key Structural Boundaries:
Breakout Trigger: Reclaiming and breaking the ATH around 7.40 EGP with renewed momentum 🚀
First Target: 7.40 EGP, the previous ATH 🎯
Second Target: 7.80 EGP, my calculated fair value 💰
Final Target: 9.80 EGP, the long-term Fibonacci extension target 🚀
🛡️ Risk Management:
As long as RMDA remains above 5.75 EGP, I would not exit the position. 🛡️
A confirmed break below 5.75 EGP would weaken the current bullish structure and invalidate my long-term setup. ⚠️
🎯 Verdict:
RMDA is going through a normal cooling phase after reaching the triangle extension target. 📊
The low liquidity during the pullback is a positive sign and does not currently indicate aggressive distribution. 📉
The key level remains 5.75 EGP, and holding above it keeps the long-term bullish thesis alive. 📈
I would treat RMDA as a long-term investment and look for another bullish wave toward 7.40 EGP, 7.80 EGP and eventually 9.80 EGP. 🎯
🕌 Sharia Compliance:
Status: Compliant, subject to the latest EGX 33 Shariah Index screening. ☪️
RMDA is included in the EGX 33 Shariah Index, but investors should verify the latest screening before making a Sharia-based investment decision. 📋
If you like my insights, follow and boost! 🙌💙🚀 🎁 $15 TradingView Discount: tradingview.com/pricing/?share_your_love=mnmabroukw36ix ✨💸🤑
Exención de responsabilidad
La información y las publicaciones no constituyen, ni deben considerarse como, asesoramiento o recomendaciones financieras, de inversión, de trading u otro tipo, proporcionadas o respaldadas por TradingView. Obtenga más información en Condiciones de uso.
Exención de responsabilidad
La información y las publicaciones no constituyen, ni deben considerarse como, asesoramiento o recomendaciones financieras, de inversión, de trading u otro tipo, proporcionadas o respaldadas por TradingView. Obtenga más información en Condiciones de uso.